AARON JASSO: Open Payments
NPI 1811334246 · ROSWELL, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,528 in 41 payments from 13 companies in 2025. Trend: 2023 $146 · 2024 $1,217 · 2025 $2,528
Speaker / faculty: $1,750Food & beverage: $675Travel & lodging: $104
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $1,993 |
| Axsome Therapeutics, Inc. | 6 | $140 |
| Lundbeck LLC | 4 | $76 |
| Alkermes, Inc. | 3 | $61 |
| HARMONY BIOSCIENCES LLC | 2 | $52 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
Products named: VRAYLAR, Auvelity, REXULTI, ARISTADA, WAKIX, COBENFY, Qelbree, AUSTEDO XR.
Industry payments across NM — which companies pay providers there.
